Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 51 - 60 of 222 for bay. (0.07 seconds)

For Good Results, Stick with the Tried and Tested. More...
Biotech Moves Up While More Painkillers Show...
CB 200 Shows Relative Strength. More details...
Is Onyx a Bargain?. More details...
Trading Calm After Yesterday's Slide. More details...
Bouncing Off 2005 Low, Biotech Gains While Market Slips....
Cancer Drug Reaches Surrogate Endpoint. More details...
Biotech Gets a Boost From Good Clinical News. More...
Tech is Becoming a Commodity. More details...
Broad Market Pulls Off Small Gain. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital